Patentablauf strattera

Aug 4, 2011 · The applicants envisaged that this compound could be useful in the treatment of ADHD, and filed the ’590 patent after submitting an Investigational New Drug application to the FDA. Strattera (atomoxetine) is a medication used to treat attention-deficit hyperactivity disorder (ADHD)

2024-03-29
    Finca hannover
  1. The patent had been set to expire in May of 2017
  2. Drug: Strattera (atomoxetine) Phase 4
  3. It belongs to the group of medicines called selective
  4. This is not a complete list of side effects and others may occur
  5. yellow eyes or skin
  6. vomiting
  7. Other meds
  8. 4cm on average, 0
  9. constipation *
  10. It is also not a controlled substance
  11. It is important that you keep these appointments